Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV Lidocaine vs Morphine for Severe Pain in ED
NCT02912195Phase 4Completed
- Sponsor
- Alameda Health System
- Start
- Mar 2016
- Primary completion
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Lidocaine Hydrochloride Injection, without epinephrine in pain (2 arms), sponsored by Alameda Health System. Primary endpoint: Pain Score (NRS 0-10). Started Mar 2016; status: completed.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrine
03
Conditions
pain
Beyond the preview
Go deeper on NCT02912195.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02912195.